The therapy of 10% Cantharides extract in treating 50 cases of perennial allergic rhinitis(PAR) was studied. The extract was plastered and blistered on Dazhui and Neiguan points. It was observedby nasal mucosa provoca...The therapy of 10% Cantharides extract in treating 50 cases of perennial allergic rhinitis(PAR) was studied. The extract was plastered and blistered on Dazhui and Neiguan points. It was observedby nasal mucosa provocative test, cells in nasal secretion test and serum total IgE test. The results showedthat ite effective rate was 88% . After treatment the allergic nasal mucosa provocative test of the treatedgroup was alleviated obviously ( P < 0 . 01 ) and the number ot eosinopnil affd basophil in nasal secretion de-creased significantly ( P < 0 . 01 , P < 0 . 05 ) . The serum total lgE also reduced significantly I P < 0 . 01 ) .展开更多
《变应性鼻炎及其对哮喘的影响》(Allergic rhinitis and its impact on asthma,ARIA)指南最新修订版(简称ARIA2010版)最近由《Journal of Allergy and Clinical Immunology》杂志全文发表。与旧版ARIA指南使用循证医学的方法不同,ARIA2...《变应性鼻炎及其对哮喘的影响》(Allergic rhinitis and its impact on asthma,ARIA)指南最新修订版(简称ARIA2010版)最近由《Journal of Allergy and Clinical Immunology》杂志全文发表。与旧版ARIA指南使用循证医学的方法不同,ARIA2010版采用推荐、评估、发展和评价分级(Grading of Recommendations,Assessment,Development and Evaluation,GRADE)工作组提出的透明的、系统化的方法修订了临床建议,以提高其实用价值。展开更多
多年来,对变应性鼻炎患者进行药物治疗的目的多以控制症状为主,疗效评价标准也以症状改善程度为主。《变应性鼻炎及其对哮喘的影响》(Allergic Rhinitis and Its Impacton Asthma,ARIA,2001)指南推荐的病情分类和阶梯性治疗方案也...多年来,对变应性鼻炎患者进行药物治疗的目的多以控制症状为主,疗效评价标准也以症状改善程度为主。《变应性鼻炎及其对哮喘的影响》(Allergic Rhinitis and Its Impacton Asthma,ARIA,2001)指南推荐的病情分类和阶梯性治疗方案也多以症状为基础,因此对症状控制的程度也成为评价某一药物疗效的“金标准”,一旦症状得以控制,药物治疗也随之停止。但最近公布的ARIA(2008)”勺虽调,对经过药物控制,症状消失或仍有轻微症状者仍应继续给予与药物治疗。展开更多
文摘The therapy of 10% Cantharides extract in treating 50 cases of perennial allergic rhinitis(PAR) was studied. The extract was plastered and blistered on Dazhui and Neiguan points. It was observedby nasal mucosa provocative test, cells in nasal secretion test and serum total IgE test. The results showedthat ite effective rate was 88% . After treatment the allergic nasal mucosa provocative test of the treatedgroup was alleviated obviously ( P < 0 . 01 ) and the number ot eosinopnil affd basophil in nasal secretion de-creased significantly ( P < 0 . 01 , P < 0 . 05 ) . The serum total lgE also reduced significantly I P < 0 . 01 ) .
文摘《变应性鼻炎及其对哮喘的影响》(Allergic rhinitis and its impact on asthma,ARIA)指南最新修订版(简称ARIA2010版)最近由《Journal of Allergy and Clinical Immunology》杂志全文发表。与旧版ARIA指南使用循证医学的方法不同,ARIA2010版采用推荐、评估、发展和评价分级(Grading of Recommendations,Assessment,Development and Evaluation,GRADE)工作组提出的透明的、系统化的方法修订了临床建议,以提高其实用价值。
文摘多年来,对变应性鼻炎患者进行药物治疗的目的多以控制症状为主,疗效评价标准也以症状改善程度为主。《变应性鼻炎及其对哮喘的影响》(Allergic Rhinitis and Its Impacton Asthma,ARIA,2001)指南推荐的病情分类和阶梯性治疗方案也多以症状为基础,因此对症状控制的程度也成为评价某一药物疗效的“金标准”,一旦症状得以控制,药物治疗也随之停止。但最近公布的ARIA(2008)”勺虽调,对经过药物控制,症状消失或仍有轻微症状者仍应继续给予与药物治疗。